Human AKR1B10 ELISA Kit (V2LY-0626-LY3803)

Liu, R., Zheng, S., yan Yang, C., Yu, Y., Peng, S., Ge, Q., ... & Shao, Y. (2021). Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis. Medicine, 100(14).

Chen, D., Shen, Z., Cheng, X., Wang, Q., Zhou, J., Ren, F., ... & Huang, R. (2021). Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression. Bioengineered, 12(1), 1964-1975.

Kanno, M., Kawaguchi, K., Honda, M., Horii, R., Takatori, H., Shimakami, T., ... & Kaneko, S. (2019). Serum aldo–keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis. Journal of gastroenterology, 54(6), 549-557.

Ye, X., Li, C., Zu, X., Lin, M., Liu, Q., Liu, J., ... & Cao, D. (2019). A large‐scale multicenter study validates aldo‐keto reductase family 1 member B10 as a prevalent serum marker for detection of hepatocellular carcinoma. Hepatology, 69(6), 2489-2501.

Shi, J., Chen, L., Chen, Y., Lu, Y., Chen, X., & Yang, Z. (2019). Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma. Journal of Cancer, 10(20), 4892.

Liu, W., Song, J., Du, X., Zhou, Y., Li, Y., Li, R., ... & Wang, Q. (2019). AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model. Acta biomaterialia, 91, 195-208.

Han, C., Gao, L., Zhao, L., Sheng, Q., Zhang, C., An, Z., ... & Dou, X. (2018). Immunohistochemistry detects increased expression of aldo-keto reductase family 1 member b10 (AKR1B10) in early-stage hepatocellular carcinoma. Medical science monitor: international medical journal of experimental and clinical research, 24, 7414.

Han, C., Gao, L., Bai, H., & Dou, X. (2018). Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma. Oncology Letters, 16(6), 7123-7130.

Zhou, Z., Zhao, Y., Gu, L., Niu, X., & Lu, S. (2018). Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10. Molecular medicine reports, 17(2), 2153-2160.

Mori, M., Genda, T., Ichida, T., Murata, A., Kamei, M., Tsuzura, H., ... & Watanabe, S. (2017). Aldo‐keto reductase family 1 member B10 is associated with hepatitis B virus‐related hepatocellular carcinoma risk. Hepatology Research, 47(3), E85-E93.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols